Navigation Links
CEL-SCI Presents Data at American College of Rheumatology Conference Which Suggests that CEL-2000 Has Potential to Slow Damage Caused by Rheumatoid Arthritis
Date:10/19/2009

x.com/acr/2009/webprogram/Paper10996.html.

CEL-SCI Corporation is developing products that empower immune defenses. Its lead product is Multikine® which is being readied for a global Phase III trial in advanced primary head and neck cancer. CEL-SCI is also developing a treatment for hospitalized H1N1 patients using its L.E.A.P.S. technology platform and expects to soon finish the validation of its state-of-the-art facility in Maryland.

When used in this report, the words "intends," "believes," "anticipated" and "expects" and similar expressions are intended to identify forward-looking statements. Such statements are subject to risks and uncertainties which could cause actual results to differ materially from those projected. Factors that could cause or contribute to such differences include, lack of regulatory clearance to proceed with clinical trials, an inability to duplicate the clinical results demonstrated in clinical studies that have been completed or that are initiated in the future, timely development of any potential products that can be shown to be safe and effective, unwillingness of regulatory authorities to engage in further regulatory dialogue, receiving necessary regulatory approvals, difficulties in manufacturing any of the Company's potential products, inability to raise the necessary capital, and the risk factors set forth from time to time in CEL-SCI Corporation's SEC filings, including but not limited to its report on Form 10- K/A for the year ended September 30, 2008. The Company undertakes no obligation to publicly release the result of any revision to these forward-looking statements which may be made to reflect the events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

For more information, please visit www.cel-sci.com

SOURCE CEL-SCI Corporation


'/>"/>
SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Comprehensive Review of Cancer Immnunotherapies Published By CEL-SCI
2. CEL-SCI Corporation Announces Adoption of Shareholder Rights Plan
3. CEL-SCI Corporation Releases Letter to Shareholders
4. CEL-SCI CORPORATION Announces Results of 2008 Annual Meeting of Shareholders and Provides Update on Ground-breaking Activities Regarding Construction of Manufacturing Facility for Pivotal Phase III Cancer Trial
5. CEL-SCI Corporation Reports Second Quarter 2008 Financial Results
6. CEL-SCI Presents Favorable Data for Leaps Vaccine Technology at Prestigious Immunology Conference
7. CEL-SCI Launches Study to Determine Long Lasting Beneficial Effects of its Rheumatoid Arthritis Vaccine
8. CEL-SCI Announces Exclusive Licensing Agreement for Cancer Drug Multikine(R) for Republic of South Africa
9. CEL-SCI Corporation Reports 2009 Second Fiscal Quarter Financial Results
10. CEL-SCI Expands Testing of Its Vaccine to Determine Efficacy Against More Virulent Strain of H1N1 Swine and Other Influenza Viruses
11. CEL-SCI Scientist Invited to Discuss Plans to Launch Unique Manufacturing Process That Saves Cost While Enhancing the Shelf Life of Drugs at 5th Annual Aseptic Processing of Sterile Drug Products Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... New York (PRWEB) June 19, 2013 ... comprehensive understanding and unprecedented access to the drug delivery ... leading healthcare companies. , The report provides a ... enter drug delivery partnering deals. The majority of deals ... a right or an option right to license the ...
(Date:6/18/2013)... June 18, 2013 Senior drug regulatory officials ... June 25 to discuss—for the first time in the U.S.—the ... drugs through the regulatory process in a timely manner. Representatives ... will share respective best practices and processes in drug review ... panel at the DIA 2013 49th Annual Meeting ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Biomet ... continue to move forward in a multidistrict litigation in ... LLP reports. According to court records, the litigation’s ... at which time the Court also convened a motions ... issues pertinent to the Biomet hip replacement litigation. ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Internationally ... his new website, thebestbreast.com, showcasing his unique approach ... with information about his surgical method and highlights ... Outlined on his website, Dr. Tebbetts compares his ... traditional methods, Dr. Tebbetts’ method does not necessitate ...
(Date:6/18/2013)... at Case Western Reserve University,s College of Arts ... made available avatarsvirtual patientsto train speech-language pathologists. ... to evaluate speech-language disorders to practice using an ... because a diagnosis doesn,t have to be made ... studying to become speech-language pathologists have previously relied ...
Breaking Medicine News(10 mins):Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 2Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 3Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 4Health News:Renowned Regulatory Representatives From Mainland China and Taiwan to Discuss Need for Collaboration at DIA Meeting 2Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 2Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 3Health News:Internationally Acclaimed Breast Augmentation Expert Announces the Launch of His New Website 2Health News:SimuCase avatars advance speech-language pathology training 2
... the International Journal of Cancer it was found that drinking ... risk of developing bile stones. ,Billiary tract cancers ... other hand are seen in women and are linked to ... had undergone treatment for billiary tract cancer live over five ...
... jaundice at Pahihari village near here has caused a scare ... ,The local Primary Health Centre (PHC) here today constituted ... vulnerable to the diseases, they said., ,At least one ... suffering from either malaria or jaundice, the officials said., ...
... foods to the U.S., China, and Japan using vacuum ... ,Local food manufacturer, Terry Tan and Singapore Polytechnic are ... available worldwide. ,Extending shelf life to one ... Terry Tan’s plans a reality. According to Samuel Aw, ...
... flesh and a few dollars more. This might seem sickening, ... falling sick and dying and if that happens, //they hit ... trading or betting on someone’s life is unabashedly termed 'Life ... undoubtedly hope after a hopeless situation and a saving grace ...
... cough syrups, is actually no better than placebo or ... seems to deal effectively with suppressing cough, but actually ... a study on 24 patients with chronic obstructive pulmonary ... in the Journal of Allergy and Clinical Immunology. The ...
... took part in a workshop to discuss the various ... and the West have different approaches to cosmetic surgery. ... like leprosy and burns than on aesthetic surgery," Anil ... Indo-Italian workshop, Aesthetica 2006. ,He added: "But of ...
Cached Medicine News:
(Date:6/18/2013)... Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ... of injectable drug delivery systems, today announced the launch ... The new site includes additional products, videos, features, blogs ... regular basis. Mr. Alan Shortall , ... leader for injectable drug delivery systems, we have created ...
(Date:6/18/2013)... 18, 2013 MPR is excited to unveil ... edition. It,s all part of an ongoing effort to freshen ... practitioners for over 28 years. (Photo: ... evolution MPR has expanded upon its foundation as ... to include an increasing array of clinical and practice management ...
(Date:6/18/2013)... June 18, 2013 New-generation electronic designs ... portable and lightweight. Simultaneously, circuitry is increasing the ... speed to which it performs at. Connecting cables ... and military equipment, such as cameras or detectors, ... and nano-circular connectors include custom cable designs for ...
Breaking Medicine Technology:Unilife Launches New Corporate Website 2MPR Sports a Bold New Look 2Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2
1-Day Acuvue brand contact lenses offer the healthiest, most convenient way to wear contact lenses. There's no lens care or messy solutions required, just wear them one day and throw them away....
... Magellan Mapper connects via a ... or desktop computer featuring Windows ... state of the art corneal ... bright ring projection and easy ...
... Oculus Easygraph is a corneal topographer ... you need for refractive surgery, contact ... contact lens fitting in a small ... package. All you need to supply ...
Available in 10 beautiful opaque colors....
Medicine Products: